Mounjaro is a weekly injection, not a daily one — here is how the schedule works

Mounjaro is a once-weekly subcutaneous injection, one dose per week, same day each week, not daily.
Each KwikPen holds four weekly doses; treatment begins at 2.5 mg and is titrated by the prescriber, typically in four-week steps.
Tirzepatide has a long half-life, which is why weekly dosing is enough to maintain steady appetite regulation and blood-sugar effects.
If a dose is missed, what to do next depends on timing, always follow the Patient Information Leaflet and ask your prescriber rather than guessing.

Mounjaro (tirzepatide) is injected once a week, not once a day. Each pre-filled KwikPen contains four doses, one for each week of the month, and you use it on the same chosen day every week. That single weekly injection is enough because tirzepatide stays active in the body for seven days, gradually tapering between doses. These are prescription-only medicines; a clinician reviews your health picture before any treatment begins, and the dosing schedule is set by your prescriber, not self-selected. If you have been wondering whether you missed a daily jab — you have not. How often Mounjaro is injected is one of the most common questions our prescribers hear in the first week of treatment, and the answer is simpler than most people expect.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The Mounjaro weekly injection schedule: what actually happens from pen to dose

Step 1: picking your injection day and sticking to it

The first practical step is choosing a day of the week that suits your routine, a Monday morning, a Sunday evening, whatever fits. That day becomes your injection day for the duration of treatment. Because tirzepatide's effects last seven days, consistency matters more than perfection: NHS guidance on tirzepatide on the NHS website confirms you can shift your injection day by a day or two if needed, provided you keep at least three days between doses, but your prescriber will walk you through this if it ever comes up.

One misconception worth letting go gently: some people start Mounjaro expecting to inject it the way they might take a daily tablet, each morning, religiously. It does not work that way. The medicine is designed for weekly use, and injecting it more often than prescribed would not speed results; it would simply put you outside the licensed schedule and increase the risk of side effects.

Once you have chosen your day, the pen goes back in the fridge until you need it. Rotate your injection site each week, abdomen, thigh and upper arm are all suitable locations, and there is more detail on using the upper arm as an injection site if that is your preference.

Step 2: the dose-escalation sequence the prescriber sets

Treatment starts at 2.5 mg. That first dose exists to give your body time to adjust, not to produce immediate weight loss, its job is to reduce early nausea and help you settle into the medicine. The prescriber then increases the dose roughly every four weeks, moving through 5 mg, 7.5 mg and potentially higher, up to the licensed maximum of 15 mg, based on how you are tolerating treatment and how your weight is responding.

Throughout every step of this sequence, the injection stays weekly. The escalation changes the strength of each dose, not the frequency. NICE's appraisal of tirzepatide, TA1026, describes the titration pathway in detail for those who want to read the clinical rationale. If at any point you are unsure whether a dose increase is right for your situation, that is a conversation for your prescriber, the schedule is personalised, not one-size.

For context on what tirzepatide is and how it works at a pharmacological level, the Mounjaro overview page covers the dual GIP and GLP-1 receptor mechanism in plain language, and if you are curious about tirzepatide injection in its generic form, that page explains what the generic designation means and how it relates to the branded product.

Step 3: the injection itself and what to expect around it

Using the KwikPen is a relatively short process. Clean the chosen site with an alcohol swab, pinch the skin gently, press the pen against it and hold until the click confirms the dose is delivered. The full technique (including how to position the pen and how long to hold it) is covered in the step-by-step Mounjaro injection guide.

The most common effects to expect in the first day or two after each dose are gastrointestinal: nausea, occasional loose stools, or a noticeable reduction in appetite. These tend to be most pronounced after a dose increase and usually ease within a few days as the body adjusts. Staying well hydrated and eating smaller, lower-fat meals around injection day can help. If side effects feel severe or persistent, contact your prescriber rather than adjusting the dose yourself.

Storage between doses is straightforward: the pen stays refrigerated at 2–8°C. The exact window for keeping it at room temperature if refrigeration is temporarily unavailable is stated in the Patient Information Leaflet; defer to that rather than memory.

What the weekly schedule means for accessing treatment

Because you are using one pen a month, treatment costs are quoted per pen or per four-week period. If you are comparing providers, it is worth reading what each price actually includes, some quote the pen cost only, with consultation fees, prescription fees and delivery added separately. There is a straightforward breakdown of what Mounjaro costs in practice, including what those headline figures often leave out, on the Mounjaro cost page.

At nume, a single transparent price covers your consultation, the clinical prescription review, the treatment itself, and free next-working-day tracked delivery. There is no subscription; each repeat order goes through a fresh clinical review by a GPhC-registered prescriber on our clinical team, not an automated system. That review checks your progress before the next pen is dispatched.

Mounjaro is a prescription-only medicine. The route to it through any legitimate UK provider (NHS or private) runs through a clinical assessment first. If you would like to find out whether you might be suitable, speak to our prescribers via a free consultation and they will review your health picture the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions